Drug Pricing Evolution in Hepatitis C.

Drug Pricing Evolution in Hepatitis C.

OBJECTIVE:We aimed to determine the association between the stepwise increase in the sustained viral response (SVR) and Swiss and United States (US) market prices of drug regimens for treatment-naive, genotype 1 chronic hepatitis C virus (HCV) infection in the last 25 years. We identified the follow...

Full description

Bibliographic Details
Main Authors: Nathalie Vernaz, François Girardin, Nicolas Goossens, Urs Brügger, Marco Riguzzi, Arnaud Perrier, Francesco Negro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4911078?pdf=render

Internet

http://europepmc.org/articles/PMC4911078?pdf=render

Similar Items